Cargando...
Pimavanserin (Nuplazid™) for the treatment of Parkinson disease psychosis: A review of the literature
INTRODUCTION: Pimavanserin (Nuplazid™) is an atypical antipsychotic currently indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis. The antipsychotic effects of this new agent are believed to occur via selective inverse agonist activity at serotonin...
Gardado en:
| Publicado en: | Ment Health Clin |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007714/ https://ncbi.nlm.nih.gov/pubmed/29955528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.09.230 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|